Charles River Labs Intl buy UBS Group AG
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€269.47
Performance (%)
-36.02%
End price
16.02.25
€145.75
Summary
This prediction ended on 16.02.25 with a price of €145.75. Massive losses of -36.02% were the result for the BUY prediction by UBS_Group_AG. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 2.761% | 2.761% | 27.530% |
| iShares Core DAX® | -0,68 % | 4,05 % | 2,21 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % | 38,04 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % | 59,00 % |
| iShares S&P 500 | 0,62 % | 6,20 % | 26,15 % |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $270.00 to $290.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€195.30
07.11.24
07.11.24
€231.75
07.11.25
07.11.25
-25.40%
08.11.25
08.11.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€184.90
08.08.24
08.08.24
€220.15
08.08.25
08.08.25
-31.34%
09.08.25
09.08.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
26.14%
10.11.24
10.11.24